WHO ICTRP trial
To observe the effect of Ayurvedic medicine for the treatment of COVID-19
CTRI/2020/05/025214 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/05/025214 |
|---|---|
| Public title | To observe the effect of Ayurvedic medicine for the treatment of COVID-19 |
| Scientific title | A Randomized, Open Label, Parallel Efficacy, Active Control, Exploratory Clinical Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation (AYUSH 64) as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients |
| Primary sponsor | Central Council for Research in Ayurvedic Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: AYUSH 64: Dose:2 capsules (500 mg each) thrice daily Dosage form:Capsules/Tablets Route of Administration: Oral Time of Administration: Thrice a day after food Anupana: Water Duration of therapy: 30 days Control… |
| Registration date | May 15, 2020 |
| Target size | 80 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: